|
1
|
Henske EP, Jóźwiak S, Kingswood JC,
Sampson JR and Thiele EA: Tuberous sclerosis complex. Nat Rev Dis
Primers. 2(16035)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Northrup H and Krueger DA: International
Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis
complex diagnostic criteria update: Recommendations of the 2012
international tuberous sclerosis complex consensus conference.
Pediatr Neurol. 49:243–254. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nabbout R, Belousova E, Benedik MP, Carter
T, Cottin V, Curatolo P, Dahlin M, D´Amato L, D'Augères GB, de
Vries PJ, et al: Epilepsy in tuberous sclerosis complex: Findings
from the TOSCA study. Epilepsia Open. 4:73–84. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Davis PE, Filip-Dhima R, Sideridis G,
Peters JM, Au KS, Northrup H, Bebin EM, Wu JY, Krueger D and Sahin
M: Tuberous Sclerosis Complex Autism Center of Excellence Research
Network. Presentation and diagnosis of tuberous sclerosis complex
in infants. Pediatrics. 140(e20164040)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
De Ridder J, Lavanga M, Verhelle B,
Vervisch J, Lemmens K, Kotulska K, Moavero R, Curatolo P, Weschke
B, Riney K, et al: Prediction of neurodevelopment in infants with
tuberous sclerosis complex using early EEG characteristics. Front
Neurol. 11(582891)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chu-Shore CJ, Major P, Camposano S,
Muzykewicz D and Thiele EA: The natural history of epilepsy in
tuberous sclerosis complex. Epilepsia. 51:1236–1241.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Curatolo P and Moavero R: Can we change
the course of epilepsy in tuberous sclerosis complex? Epilepsia.
51:1330–1331. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Curatolo P, Jóźwiak S and Nabbout R: TSC
Consensus Meeting for SEGA and Epilepsy Management. Management of
epilepsy associated with tuberous sclerosis complex (TSC): Clinical
recommendations. Eur J Paediatr Neurol. 16:582–586. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rosenow F, Alonso-Vanegas MA, Baumgartner
C, Blümcke I, Carreño M, Gizewski ER, Hamer HM, Knake S, Kahane P,
Lüders H, et al: Cavernoma-related epilepsy: Review and
recommendations for management-report of the surgical task force of
the ILAE commission on therapeutic strategies. Epilepsia.
54:2025–2035. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Morrison L and Akers A: Cerebral cavernous
malformation, familial. In: GeneReviews® [Internet].
Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G and
Amemiya A (eds). University of Washington, Seattle, WA, 1993.
|
|
11
|
de Vos IJ, Vreeburg M, Koek GH and van
Steensel MA: Review of familial cerebral cavernous malformations
and report of seven additional families. Am J Med Genet A.
173:338–351. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Toll A, Parera E, Giménez-Arnau AM, Pou A,
Lloreta J, Limaye N, Vikkula M and Pujol RM: Cutaneous venous
malformations in familial cerebral cavernomatosis caused by KRIT1
gene mutations. Dermatology. 218:307–313. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Russo A, Arbune A, Bansal L, Mindruta I,
Gobbi G and Duchowny M: The localizing value of epileptic auras:
Pitfalls in semiology and involved networks. Epileptic Disord.
21:519–528. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Canevini MP, Kotulska-Jozwiak K, Curatolo
P, La Briola F, Peron A, Słowińska M, Strzelecka J, Vignoli A and
Jóźwiak S: Current concepts on epilepsy management in tuberous
sclerosis complex. Am J Med Genet C Semin Med Genet. 178:299–308.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf
N, Von Kries R, Heinrich B, Ebrahimi-Fakhari D, Flotats-Bastardas
M, Gortner L, Zemlin M and Meyer S: Incidence of tuberous sclerosis
and age at first diagnosis: New data and emerging trends from a
national, prospective surveillance study. Orphanet J Rare Dis.
13(117)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Teng JM, Cowen EW, Wataya-Kaneda M,
Gosnell ES, Witman PM, Hebert AA, Mlynarczyk G, Soltani K and
Darling TN: Dermatologic and dental aspects of the 2012
international tuberous sclerosis complex consensus statements. JAMA
Dermatol. 150:1095–1101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mihăilă B, Dinică RM, Tatu AL and Buzia
OD: New insights in vitiligo treatments using bioactive compounds
from piper nigrum. Exp Ther Med. 17:1039–1044. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tatu AL and Nwabudike LC: Male genital
lichen sclerosus-a permanent therapeutic challenge. J Am Acad
Dermatol. 79 (Suppl 1)(AB185)2018.
|
|
19
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus: Treatments
of genital lichen sclerosus. In: Proceedings of the 14th national
congress of urogynecology and the national conference of the
Romanian association for the study of pain, Eforie, pp262-264,
2017.
|
|
20
|
Portocarrero LKL, Quental KN, Samorano LP,
Oliveira ZNP and Rivitti-Machado MCDM: Tuberous sclerosis complex:
Review based on new diagnostic criteria. An Bras Dermatol.
93:323–331. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Josephson CB, Leach JP, Duncan R, Roberts
RC, Counsell CE and Al-Shahi Salman R: Scottish Audit of
Intracranial Vascular Malformations (SAIVMs) steering committee and
collaborators. Seizure risk from cavernous or arteriovenous
malformations: Prospective population-based study. Neurology.
76:1548–1554. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mouchtouris N, Chalouhi N, Chitale A,
Starke RM, Tjoumakaris SI, Rosenwasser RH and Jabbour PM:
Management of cerebral cavernous malformations: From diagnosis to
treatment. ScientificWorldJournal. 2015(808314)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kashefiolasl S, Bruder M, Brawanski N,
Herrmann E, Seifert V, Tritt S and Konczalla J: A benchmark
approach to hemorrhage risk management of cavernous malformations.
Neurology. 90:e856–e863. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Moran NF, Fish DR, Kitchen N, Shorvon S,
Kendall BE and Stevens JM: Supratentorial cavernous haemangiomas
and epilepsy: A review of the literature and case series. J Neurol
Neurosurg Psychiatry. 66:561–568. 1999.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Arbune AA, Craiu D, Cuciureanu ID, Iulian
C, Pavel LL, Berbece IS, Grigore CA and Dulamea A: Challenges of
valproate treatment during pregnancy: Pros and cons. Rev Chim.
71:456–459. 2020.
|
|
26
|
Campione E, Diluvio L, Terrinoni A, Di
Stefani A, Orlandi A, Chimenti S and Bianchi L: Progressive
late-onset of cutaneous angiomatosis as possible sign of cerebral
cavernous malformations. Dermatol Online J. 19(2)2013.PubMed/NCBI
|
|
27
|
Whitworth WR, Hick RW, Nelson KC and
Sidhu-Malik NK: Cerebral cavernous malformations associated with
cutaneous angiokeratomas and hemangiomas. Cutis. 96:329–332.
2015.PubMed/NCBI
|
|
28
|
Errichetti E, Piccirillo A and Ricciuti F
and Ricciuti F: An unusual case of multiple angiokeratomas arising
on a medium-sized congenital melanocytic nevus. Indian J Dermatol
Venereol Leprol. 78:374–375. 2012.PubMed/NCBI View Article : Google Scholar
|
